Isla Campbell
Rapid Critical Metals Expands District Footprint with Webbs Drilling
Rapid Critical Metals kicks off RC drilling at Webbs Silver, expands district footprint with fully funded program and new tenure targets.
MaxiPARTS Confirms FY26 Guidance Despite Geopolitical Transport Disruptions
MaxiPARTS reaffirms FY26 guidance amid transport-disruption headwinds; guiding A$273-278m revenue and A$13.4-14.1m NPBT as cost cuts support margins.
Felix Gold Extends High-Grade Gold Intersections within Antimony System at Treasure Creek
Felix Gold hits 29.26m @2.16 g/t Au (from 13.41m) at NW Array, Treasure Creek; gold-antimony co-mineralisation strengthens dual-commodity potential.
Constellation Resources Confirms Methane and Helium Prospectivity in New Exploration Area
Constellation Resources confirms NatH2, helium and methane prospectivity in SPA-0143; CSIRO results; DMPE grants preferred applicant status; surveys planned 2H26.
Eden Innovations Taps Tony G to Lead European Defence Push for EdenShield
Eden Innovations taps Tony G to lead EdenShield's European defence push, eyeing govt contracts, EU funds, and landmark partnerships—ASX:EDE moves on.
Comet Ridge Softens Terms and Extends Timelines for Mahalo Acquisition
Comet Ridge chills Mahalo deal: upfront cash cut to $18m + $10m in shares, up to $30m contingent; funding extended to Aug 14, 2026 amid policy uncertainty.
Novatti Group's UNSW Alipay Integration Surpasses Revenue and Transaction Volume Expectations
Novatti's UNSW Alipay integration tops expectations, delivering $33.6m GMV and $0.5m revenue by Apr 30 2026; UNSW first AU uni on Xetta.
Nyrada Announces Preclinical Oncology Efficacy for Xolatryp and US Patent Allowance
Nyrada reports strong preclinical Xolatryp efficacy in liver cancer and a US patent allowance, highlighting a ~39% boost vs doxorubicin alone.
RAS Technology Secures $2M+ Annualised Revenue Boost from New Deals and Contract Extensions
RAS Technology lifts annualised revenue by $2m+ from Altenar, TABtouch, and LeoVegas; Asia momentum fuels growth after H1 38% revenue rise.
OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device
OncoSil Medical wins TGA approval for OncoSil device to treat unresectable LAPC; ARTG-listed, enabling Australian launch as manufacturing scales up.
Mach7 Technologies Lands New US Customer AMRADNET on 5-Year Deal
Mach7 wins US AMRADNET deal worth A$1.7M, 5-year ARR; deployment cut to 45 days, signaling accelerated growth post-transformation.
MyEco Group Lands Penrith Council FOGO Liner Contract
MyEco Group wins Penrith City Council FOGO liner contract worth up to $6.83m over five years (avg $1.36m p.a.), starts May 15, 2026.
Gold Hydrogen to Accelerate Helium Commercialisation at Ramsay Project after Positive Assessment
Gold Hydrogen accelerates Ramsay helium via two wells (~29 Mscf/d); Worley positive, June 2026 flow-testing to lock in FEED.
Vista Group Inks Major Six-Year Cloud Deal with Cinépolis Mexico
Vista Group inks six-year cloud deal with Cinépolis Mexico for 504 sites and 4,100 screens; rollout starts 2026, signaling strong Vista Cloud momentum.
Is Indium the Next Critical Mineral to Watch in the Small Caps Space?
Indium surges as supply tightness and China export curbs boost demand in AI photonics, ITO and solar; a must-watch for small-cap investors.
Provaris Energy Partners With 'K' LINE and Norwegian Hydrogen to Build Compressed H2 Supply Chain
Provaris Energy partners with K LINE and Norwegian Hydrogen to build a compressed H2 export chain from Norway to Northern Europe, advancing the FjordH2 project.
Koonenberry Gold Acquires High-Grade Gundagai Gold-Copper Project in NSW
Koonenberry Gold to acquire Gundagai Gold-Copper Project in NSW, expanding Lachlan Fold Belt footprint by 485km2; high-grade gold/copper assays; MD transition.
Synertec Executes LOI for Major Digital Systems Energy Project
Synertec secures non-binding LOI for a multi-million energy project; trading halt until definitive terms, two-year scope with Hitachi Energy tie-in.
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Condor Energy Applies for Peru Licence Contract after Securing 100% Interest in Tumbes Basin Block
Condor Energy seeks Peru TEA-86 Licence Contract after a 100% stake; 3.3B bbl oil potential and 1 Tcf gas. Perupetro approval hurdle; A$2.25m raise funds ahead.